ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2504

SOCS1 Is One of the Key Molecules to Prevent the Plasticity of Regulatory T Cells and the Development of Autoimmunity

Reiko Takahashi1, Kenji Itoh1, Fumihiko Kimura1 and Akihiko Yoshimura2, 1Division of Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan, 2Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, regulatory cells and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Suppression of autoimmunity or inflamation by regulatory T cells (Tregs) is now well established, recently, natural Foxp3+T cells have been shown to be a heterogeneous population consisting of a committed Treg lineage and an uncommitted subpopulation with developmental plasticity. Tregs have been reported to convert into Th1- or Th17-like cells (exFoxp3 cells) under lymphopenic or inflammatory conditions, which might be one of causes of autoimmunity. SOCS1 is defined as an important mechanism for the negative regulation of the cytokine-JAK-STAT pathway. SOCS1-deletion specifically in T cells (LckCre-SOCS1-flox mice) or Tregs (Foxp3Cre-SOCS1-flox mice) induced lupus-like phenomenon such as dermatitis, splenomegaly and lymphoadenopathy, suggesting a defective Treg function in these mice.

We examined the role of SOCS1 to maintain the Foxp3 expression or suppressive functions in natural Tregs.

Methods:

•Natural Tregs (CD3+CD4+CD25+Foxp3GFP) from LN of wild type (WT), LckCre-SOCS1-flox, or Foxp3Cre-SOCS1-flox mice sorted by flowcytometry

•Transfer of Treg cells with naïve T cells into Rag2-/-mice

•Single transfer of Tregs into Rag2-/-mice

•Tregs cultured with CD3/CD28 or antigen presenting cells in vitro

Results:

1) SOCS1+/+ Tregs from WT mice efficiently suppressed colitis induced by naive CD4+ T cell transfer into Rag2-/- mice, however, SOCS1-/- Tregs from LckCre-SOCS1-flox mice could not prevent it (n=3). Only SOCS1-/- Tregs transferred into Rag2-/- mice caused colitis, lost Foxp3 expression more rapidly, and converted into IFNγ-producing cells accompanying with hyperactivation of STAT1 (n=3). Foxp3 was stable in IFNγ-/-SOCS1-/-Tregs (n=3).

2) Because Tregs from LckCre-SOCS1-flox mice were constantly exposed to inflammatory cytokines from non-Treg cells in vivo, we then analyzed Treg specific SOCS1 deficient mice (Foxp3Cre-SOCS1-flox). Tregs from Foxp3Cre-SOCS1-flox mice maintained Foxp3 expression transferred into Rag2-/-mice, on the contrary, those from LckCre-SOCS1-flox mice (n=3).

3) Tregs from LckCre-SOCS1-flox mice produced IFNγ after culture with CD3/CD28 in vitro, however, Tregs from Foxp3Cre-SOCS1-flox mice did not (n=3). When Tregs from Foxp3Cre-SOCS1-flox mice were cultured with antigen presenting cells (APCs) from LckCre-SOCS1-flox mice, they produced IFNγ, which was blocked by anti-IL-12 antibodies (n=3).

Conclusion: SOCS1 plays important roles in maintaining Foxp3 expression and is necessary for suppression activity of Tregs by regulating STAT1 under inflammatory conditions in which APCs are highly activated.


Disclosure:

R. Takahashi,
None;

K. Itoh,
None;

F. Kimura,
None;

A. Yoshimura,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/socs1-is-one-of-the-key-molecules-to-prevent-the-plasticity-of-regulatory-t-cells-and-the-development-of-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology